Immediate Impact
24 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Bingyang Hu being referenced
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bingyang Hu | 171 | 193 | 80 | 103 | 18 | 350 | |
| Alagappan Annamalai | 113 | 133 | 50 | 58 | 19 | 321 | |
| Hideki Takakura | 86 | 137 | 136 | 84 | 19 | 374 | |
| Bashar Zeidan | 159 | 112 | 87 | 91 | 21 | 361 | |
| Alexander Hendricks | 138 | 132 | 38 | 88 | 25 | 382 | |
| Gaofeng Sun | 119 | 111 | 46 | 48 | 21 | 322 | |
| Jorge Adeva | 221 | 194 | 22 | 111 | 19 | 338 | |
| Khaldoun Kerrou | 98 | 117 | 51 | 107 | 21 | 410 | |
| J. Schüller | 99 | 170 | 30 | 53 | 28 | 399 | |
| Yoshihiro Noda | 163 | 119 | 64 | 127 | 26 | 328 | |
| Na Zhao | 89 | 67 | 53 | 152 | 18 | 375 |
All Works
Loading papers...